Thrombolex, Inc.
6 private offerings reported to the SEC on Form D since 2016, $55.6M sold in all. Other health care, NJ.
- Form D offerings: 6
- Reported sold: $55.6M
- Newest: Mar 12, 2026
- FDA records: Company page
Every Form D Offering
Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.| Mar 12, 2026 | $32.8M | $51.1M | Thrombolex, Inc.Other health care · NJ | Not amended | 0001703764-26-000003 |
| Jun 21, 2024 | $1.2M | $5.0M | Thrombolex, Inc.Other health care · NJ | Not amended | 0001703764-24-000002 |
| May 28, 2024 | $4.8M | $4.8M | Thrombolex, Inc.Other health care · NJ | Not amended | 0001703764-24-000001 |
| Aug 30, 2022 | $2.0M | $2.0M | Thrombolex, Inc.Other health care · NJ | Not amended | 0001703764-22-000001 |
| Nov 29, 2021 | $5.0M | $5.0M | Thrombolex, Inc.Other health care · NJ | Not amended | 0001703764-21-000001 |
| Apr 17, 2017 | $9.8M | $1.5M | Thrombolex, Inc.Other health care · PA | Feb 3, 2020 | 0001703764-17-000001 |
SEC Profile
From the company's EDGAR record- Business address
- Doylestown, Pa
- Incorporated in
- DE
- All SEC filings
- CIK 1703764 on EDGAR
- FDA records
- Approvals, clearances, recalls and letters
A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR